Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Firefly Neuroscience (AIFF) over the last 14 years, with Q3 2025 value amounting to $86000.0.

  • Firefly Neuroscience's Capital Expenditures rose 205000.0% to $86000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $185000.0, marking a year-over-year increase of 17205.88%. This contributed to the annual value of $148000.0 for FY2024, which is N/A changed from last year.
  • Firefly Neuroscience's Capital Expenditures amounted to $86000.0 in Q3 2025, which was up 205000.0% from $12000.0 recorded in Q2 2025.
  • Firefly Neuroscience's Capital Expenditures' 5-year high stood at $301842.0 during Q4 2022, with a 5-year trough of $4000.0 in Q3 2024.
  • Moreover, its 4-year median value for Capital Expenditures was $18551.0 (2021), whereas its average is $61332.6.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 209617.29% in 2022, then plummeted by 8125.0% in 2025.
  • Firefly Neuroscience's Capital Expenditures (Quarter) stood at $13744.0 in 2021, then skyrocketed by 2096.17% to $301842.0 in 2022, then plummeted by 73.5% to $80000.0 in 2024, then grew by 7.5% to $86000.0 in 2025.
  • Its last three reported values are $86000.0 in Q3 2025, $12000.0 for Q2 2025, and $7000.0 during Q1 2025.